Price $7.55 |
Market Cap
2.35B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
16.9
|
P/B
1.95
|
P/S
4.94
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
11.2
|
Op. Cash Flow
277.4K
|
FCF
0.7
|
|
Op. Margin
44.60%
|
Net Margin
32.70%
|
ROE
12.90%
|
ROI
11.00%
|
|
ROA
10.10%
|
EPS Growth
-0.50%
|
Current Ratio
8.7
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Amneal Pharmaceuticals Inc (AMRX) | $1.27 | - | - | 604.1M | Strong Buy |
| Alaunos Therapeutics Inc (TCRT) | $0.60 | - | - | 137M | Strong Buy |
| Akumin Inc (AKU) | $0.74 | - | - | 108.7M | Strong Buy |
| Cidara Therapeutics Inc (CDTX) | $1.19 | - | - | 129.6M | Strong Buy |
| Akebia Therapeutics Inc (AKBA) | $0.60 | - | - | 171M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
